Integrated Diagnostics Holdings plc

(the 'Company')

TOTAL VOTING RIGHTS

1 October 2024

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, the Company hereby notifies the market of the following:

The Company's issued share capital as at 30 September 2024 consisted of 600,000,000 shares of US$0.25 each ('Ordinary Shares'), of which 18,673,728 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 581,326,272. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

Integrated Diagnostics Holdings plc

Tarek Yehia

Investor Relations Director

T: +20 (0)2 3332 1126 | M: +20 10 6882 6678 | tarek.yehia@idhcorp.com

Company Secretary

Company Matters

IDHLondon@linkgroup.co.uk

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END